Best Buy Might Be Immune From the Amazon Threat

Photo of Chris Lange
By Chris Lange Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Best Buy Might Be Immune From the Amazon Threat

© Scott Olson / Getty Images

In the e-commerce era, when brick-and-mortar retailers by and large are failing, Best Buy Co. Inc. (NYSE: BBY | BBY Price Prediction) is making a name for itself. Even considering the looming threat of Amazon, Best Buy could stand tall. At least that’s what its most recent sales report indicates.

Customers finally were allowed back into Best Buy stores at the beginning of the second quarter. This started as an in-store consultation service to customers by appointment only. On June 15, Best Buy opened its doors for customers to shop without an appointment at over 800 stores in the United States. Almost all stores were open by June 22.

Best Buy’s quarter-to-date sales as of July 18 increased roughly 2.5% compared to last year. This included domestic sales growth of 2% and international sales growth of 8%. What stands out here is that online sales growth is estimated to increase 255% year over year.

The biggest drivers of growth in sales were the computing, appliance and tablet categories.

[nativounit]

Since the company opened up a majority of its stores on June 15, it has seen sales growth of about 15%, compared to the same period last year. Also, during the quarter, Best Buy expects to see sales growth of approximately 185%.

Management was quick to point out that it had withdrawn financial guidance for the fiscal full year. Management also said that the company would provide additional business updates when it releases second-quarter results in late August.

For the fiscal second quarter, analysts expected $0.77 in earnings per share and $8.96 billion in revenue. The same period of last year reportedly had $1.08 in EPS and $9.54 billion in revenue.

Best Buy stock traded up about 9% on Wednesday to $98.24, in a 52-week range of $48.11 to $99.41. The consensus price target is $87.92.

[recirclink id=724789][wallst_email_signup]

Photo of Chris Lange
About the Author Chris Lange →

Chris Lange is a writer for 24/7 Wall St., based in Houston. He has covered financial markets over the past decade with an emphasis on healthcare, tech, and IPOs. During this time, he has published thousands of articles with insightful analysis across these complex fields. Currently, Lange's focus is on military and geopolitical topics.

Lange's work has been quoted or mentioned in Forbes, The New York Times, Business Insider, USA Today, MSN, Yahoo, The Verge, Vice, The Intelligencer, Quartz, Nasdaq, The Motley Fool, Fox Business, International Business Times, The Street, Seeking Alpha, Barron’s, Benzinga, and many other major publications.

A graduate of Southwestern University in Georgetown, Texas, Lange majored in business with a particular focus on investments. He has previous experience in the banking industry and startups.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618